Ocular manifestations of Lyme borreliosis in Europe

Mora, Paolo; Carta, Arturo

doi:10.7150/ijms.6.124

Cited by 41 publications

(32 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Eventually, atrophy develops with smooth, hairless and tissue paper like, dull red, pigmented or poikilodermatous skin. 80 Ocular involvement namely conjunctivitis, keratitis, episcleritis/scleritis, uveitis and neuro has also been reported 81 , most frequently occuring in the second and third stages. Theinvolvement is generally symptomatic , and hence routine evaluation is not warranted.…”

Section: Accepted Manuscriptmentioning

confidence: 97%

Lyme disease/borreliosis as a systemic disease

Sehgal¹,

Khurana

2015

Clinics in Dermatology

View full text Add to dashboard Cite

Section: Accepted Manuscriptmentioning

confidence: 97%

Lyme disease/borreliosis as a systemic disease

Sehgal¹,

Khurana

2015

Clinics in Dermatology

View full text Add to dashboard Cite

“…Other patients are more resistant to therapy and, despite the use of aggressive treatment, will experience permanent visual impairment. Permanent patient monitoring is very important [15].…”

Section: Resultsmentioning

confidence: 99%

The Importance of Specific Antibiotic Therapy in the Evolution of Retinal Vasculitis

Anton¹,

Alexa²,

Cantemir³

et al. 2017

Rev. Chim.

View full text Add to dashboard Cite

Ischemic retinal vasculitis is an inflammation of retinal blood vessels associated with vascular occlusion and retinal hypoperfusion. It may cause visual loss secondary to macular ischaemia, macular edema and neovascularization leading to vitreous hemorrhage, fibroblastic proliferation and retinal detachment by traction. Corticosteroids with or without immunosuppressive medication are the main treatment in retinal vasculitis associated with laser photocoagulation of retinal ischemic regions. In Lyme�s disease, etiologic treatment is achieved with Ceftriaxone that can be associated in some cases with corticosteroids. In this paper, we report about a patient who presented for the decrease of about 1.5 months of painless, asymptomatic visual acuity (VA). The patient was diagnosed with oclusive retinal vasculitis and followed a series of investigations to identify the etiology. The presence of anti-borelial antibodies required the administration of specific treatment with ceftriaxone 1g / 12h to which was added after 48h systemic corticosteroids, with slow evolution favourable. This association of retinal vasculitis - Lyme was quite rare and difficult to demonstrate. The prognosis of patients with retinal vasculitis is variable. Many patients may have a relatively benign condition or may have a dramatic response to systemic imunosuppressive therapy and will retain visual function. In the long run, despite specific treatment, it is unfavorable due to the evolution of retinal atrophy with visual field and visual function. Patients with ischemic retinal vasculitis represent a significant management challenge and, if not treated properly, can lead to a severe, irreversible visual loss.

show abstract

“…Ocular neuroborreliosis can be seen in every stage but most frequently in second and third stages [5,7,9]. Various ocular symptoms including pain, visual impairment, photophobia, diplopia and lack of accomadation may be seen [9]. Opthalmologic changes include conjuctivitis, optic neuritis and all varieties of uveitis, most commonly posterioual impairment [10].…”

Section: Discussionmentioning

confidence: 99%

Lyme Borreliosis with Opthalmologic Presentation

Gültekingil¹,

Topaloğlu²,

Orhan³

et al. 2012

OJRA

View full text Add to dashboard Cite

Lyme disease is a tick-borne multisystemic disease with multiple clinical presentations including rheumatological conditions. We present a 12 year old girl complaining of fever, arthralgia and redness in her eyes which was found to be the result of panuveitis. Borrelia antibodies were positive and she received 21-day treatment regimen with Ceftriaxon with resolution of all complaints at the end of treatment. Lyme disease classically occurs in three stages starting with erythema migrans, however atypical presentations skipping this stage and presenting with opthalmologic involvement in form of uveitis can be seen.

show abstract

Ocular manifestations of Lyme borreliosis in Europe

Cited by 41 publications

References 5 publications

Lyme disease/borreliosis as a systemic disease

Lyme disease/borreliosis as a systemic disease

The Importance of Specific Antibiotic Therapy in the Evolution of Retinal Vasculitis

Lyme Borreliosis with Opthalmologic Presentation

Contact Info

Product

Resources

About